🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Octapharma (IP) — Licensed Medicines

15 medicines held by Octapharma (IP) on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 15 products held by Octapharma (IP)
MedicineActive substanceLicence holderStatus
Albunorm 20%, 200g/l, solution for infusion
PA2219/007/002
Human plasma protein not containing less than 96% human albumin Octapharma (IP) Marketed
Albunorm 5%, 50 g/l, solution for infusion
PA2219/007/001
Human plasma protein not containing less than 96% human albumin Octapharma (IP) Marketed
CUTAQUIG, 165 mg/ml, solution for injection
PA2219/001/001
Human normal immunoglobulin Octapharma (IP) Not marketed
FIBRYGA 2 g powder and solvent for solution for injection/infusion
PA2219/011/002
Human fibrinogen Octapharma (IP) Not marketed
FIBRYGA, 1 g, powder and solvent for solution for injection/infusion
PA2219/011/001
Human fibrinogen Octapharma (IP) Marketed
LG-octaplas, Powder and solvent for solution for infusion
PA2219/002/002
Human plasma protein Octapharma (IP)
LG-octaplas, solution for infusion
PA2219/002/001
Human plasma protein Octapharma (IP) Marketed
Octanate 1000 IU powder and solvent for solution for injection
PA2219/004/003
Human coagulation factor viii Octapharma (IP) Not marketed
Octanate 250 IU.Powder and solvent for solution for injection
PA2219/004/001
Human plasmafraktion (factor viii) Octapharma (IP) Not marketed
Octanate 500 IU powder and solvent for solution for injection
PA2219/004/002
Human coagulation factor viii Octapharma (IP) Not marketed
Octaplex 1000 IU coagulation factor IX per vial, powder and solvent for solution for infusionHuman Prothrombin Complex
PA2219/005/002
Human coagulation factor ix, Human coagulation factor ii, Human coagulation factor vii, Human coagulation factor x, Protein c Octapharma (IP) Marketed
Octaplex 500 IU coagulation factor IX per vial, powder and solvent for solution for infusionHuman Prothrombin Complex
PA2219/005/001
Human plasma coagulation factor ix, Human plasma coagulation factor ii, Human plasma coagulation factor vii, Human plasma coagulation factor x, Protein c Octapharma (IP) Marketed
Panzyga, 100 mg/ml solution for infusion
PA2219/010/001
Human normal immunoglobulin Octapharma (IP) Not marketed
Wilate, 1000 IU VWF/1000 IU FVIII, powder and solvent for solution for injection
PA2219/008/002
Human factor viii, Von willebrand factor human Octapharma (IP) Marketed
Wilate, 500 IU VWF/500 IU FVIII, powder and solvent for solution for injection
PA2219/008/001
Human factor viii, Von willebrand factor human Octapharma (IP) Marketed

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.